The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...
Sen. Mike Braun has a unique opportunity to hold Novo Nordisk accountable for discontinuing insulin drug Levemir.
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
MADRID — The de-escalation of a multiple daily injection regimen of insulin for type 2 diabetes to a once-daily fixed-ratio combination of insulin glargine U100 and glucagon-like peptide 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback